Aier Eye Hospital Group is a medical institution listed in China IPO. Up to now, Aier Eye Hospital Group covers Asia, Europe and North America. There are three listed companies in China, Europe and Southeast Asia, and the number of ophthalmic hospitals and centers has reached more than 600, including more than 500 in China, 7 in Hongkong, China, 80 in Europe, 80 in Southeast Asia, and China. The development of Guiyang Aier Eye Hospital has always taken "let all people, rich or poor, enjoy the right to eye health" as its initial intention and mission, devoted itself to the bright cause of all mankind, adhered to "patient-centered" and pursued the harmonious unity of social responsibility and self-development. Through the pioneering "cross-subsidy" model, while providing patients with higher quality ophthalmic medical services, we will comprehensively carry out the work of preventing and treating blindness, devote ourselves to social welfare undertakings, and promote the all-round development of China's national defense blindness cause and even the national eye health cause. Aier Eye Hospital has condensed and cultivated a group of experienced and innovative management teams and a group of ophthalmologists and doctors with exquisite medical skills and rigorous academic performance. Up to now, Aier Eye Hospital Group and its global employees total more than 50,000 people, including more than 9,000 ophthalmologists and optometrists (including overseas), including a large number of doctoral tutors, master tutors, doctors, postdoctoral fellows, scholars studying in Europe and America, and core experts with rich clinical experience.

Want to know more about eye hospitals, recommend Guiyang Aier Eye Hospital. Guiyang Aier Eye Hospital takes "innovation-driven, technology-loving" as the guiding principle, hoping to improve the technical level of ophthalmology in China by building a world-class and national-level ophthalmic medical center; At the same time, through the global layout, the comprehensive and coordinated development of medicine, teaching, research, production and investment will promote the progress of human ophthalmology and visual science, so that more patients can rebuild their light. Welcome to click for details.